Law360, New York (April 25, 2014, 9:40 PM EDT) -- Prescription drug promotion is suddenly in a state of tremendous flux, with the legal landscape shifting rapidly amid court decisions on free speech, the Affordable Care Act's emphasis on value and the U.S. Food and Drug Administration's reappraisal of how risks are disclosed. Law360 talked with experts about the upheaval, and they named five enforcement trends to follow closely.
Cost-Effectiveness Claims Get a Closer Look
Numerous factors have led insurers and health care providers to focus more on cost-effectiveness. For one thing, insurers are now directly competing on ACA exchanges and accountable care organizations are striving to meet Medicare savings targets....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!